{
    "title": "Amgen says experimental obesity drug has promising durability",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11499277/Amgen-says-experimental-obesity-drug-promising-durability.html",
    "date": "2022-12-03",
    "keywords": [
        "trial",
        "loss",
        "dose",
        "amg133",
        "amgen",
        "drug",
        "disease",
        "body",
        "beasley",
        "midstage",
        "year",
        "company",
        "phase",
        "weight",
        "health",
        "activity",
        "gene",
        "gip",
        "mass",
        "study",
        "los",
        "obesity",
        "durability",
        "way",
        "data",
        "presentation",
        "treatment",
        "start",
        "meeting",
        "world",
        "congress",
        "insulin",
        "resistance",
        "side",
        "nausea",
        "couple",
        "control",
        "prevention",
        "population",
        "cause",
        "type",
        "heart",
        "covid19",
        "field",
        "investor",
        "attention",
        "eli",
        "co",
        "nordisk",
        "semaglutide",
        "tirzepatide",
        "hormone",
        "feeling",
        "fullness",
        "glp1",
        "mechanism",
        "time",
        "work",
        "fat",
        "haldar",
        "head",
        "discovery",
        "receptor",
        "bmi",
        "index",
        "biotech",
        "range",
        "analyst",
        "chris",
        "schott",
        "month",
        "iii",
        "launch",
        "reporting",
        "deena",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}